CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 24 | 20 | −4 |
| Shares | 1.18M | 1.73M | +558.5K (+47.5%) |
| Value | $828.0K | $589.0K | −$239.0K (−28.9%) |
New holders (4)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 111,749 | $38.0K | 0.00% |
| Beacon Financial Advisory LLC | 40,000 | $14.0K | 0.01% |
| Two Sigma Investments, LP | 25,143 | $9.00K | 0.00% |
| HighTower Advisors, LLC | 13,500 | $4.00K | 0.00% |
Sold out (8)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 11,513 | $8.00K |
| Morgan Stanley | 5,500 | $4.00K |
| UBS Group AG | 3,653 | $3.00K |
| Migdal Insurance & Financial Holdings Ltd. | 1,283 | $1.00K |
| Capital Analysts, LLC | 1,000 | $1.00K |
| CoreCap Advisors, LLC | 800 | $1.00K |
| Bank of America Corp | 177 | $0 |
| FMR LLC | 25 | $0 |